SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-042235
Filing Date
2023-07-13
Accepted
2023-07-13 17:12:24
Documents
1
Period of Report
2023-07-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4302
  Complete submission text file 0001209191-23-042235.txt   5920
Mailing Address 601 GATEWAY BOULEVARD SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address
Scopa James Paul (Reporting) CIK: 0001356950 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40794 | Film No.: 231087387

Mailing Address 400 EAST JAMIE COURT SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 400 EAST JAMIE COURT SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-566-1402
DICE Therapeutics, Inc. (Issuer) CIK: 0001645569 (see all company filings)

IRS No.: 472286244 | State of Incorp.: DE | Fiscal Year End: 1230
SIC: 2834 Pharmaceutical Preparations